Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Browse by Current Cardiff authors

Number of items: 12.

Totty, Joshua Philip, Matin, Rubeta N., Wernham, Aaron, Ray, Ruby, Thomas-Jones, Emma ORCID: https://orcid.org/0000-0001-7716-2786 and Abbott, Rachel Angharad 2022. Use of perioperative prophylactic antibiotics following excision of ulcerated skin lesions in the UK: a national, multispeciality survey of clinicians. Clinical and Experimental Dermatology 47 (5) , pp. 957-959. 10.1111/ced.15075

Mukherjee, Somnath, Hurt, Christopher ORCID: https://orcid.org/0000-0003-1206-8355, Radhakrishna, Ganesh, Gwynne, Sarah, Bateman, Andrew, Gollins, Simon, Hawkins, Maria A., Canham, Joanna ORCID: https://orcid.org/0000-0003-3482-0990, Grabsch, Heike I., Falk, Stephen, Sharma, Ricky A., Ray, Ruby, Roy, Rajarshi, Cox, Catrin, Maynard, Nick, Nixon, Lisette ORCID: https://orcid.org/0000-0002-1270-6970, Sebag-Montefiore, David J., Maughan, Timothy, Griffiths, Gareth O. and Crosby, Tom D.L. 2021. Oxaliplatin/capecitabine or carboplatin/paclitaxel-based preoperative chemoradiation for resectable oesophageal adenocarcinoma (NeoSCOPE): Long-term results of a randomised controlled trial. European Journal of Cancer 153 , pp. 153-161. 10.1016/j.ejca.2021.05.020
file

Gollins, Simon, West, Nicholas, Sebag-Montefiore, David, Susnerwala, Shabbir, Falk, Stephen, Brown, Nick, Saunders, Mark, Quirke, Philip, Ray, Ruby, Parsons, Philip, Griffiths, Gareth, Maughan, Tim, Adams, Richard ORCID: https://orcid.org/0000-0003-3915-7243 and Hurt, Christopher ORCID: https://orcid.org/0000-0003-1206-8355 2018. A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUS. British Journal of Cancer 10.1038/s41416-018-0209-4
file

Crosby, Tom, Hurt, Christopher ORCID: https://orcid.org/0000-0003-1206-8355, Falk, S, Gollins, S, Staffurth, John ORCID: https://orcid.org/0000-0002-7834-3172, Ray, Ruby, Bridgewater, J A, Geh, J I, Cunningham, D, Blazeby, J, Roy, R, Maughan, Timothy, Griffiths, Gwyn and Mukherjee, Saptarshi 2017. Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/? cetuximab in oesophageal cancer. British Journal of Cancer 116 (6) , pp. 709-716. 10.1038/bjc.2017.21
file

Mukherjee, Somnath, Hurt, Christopher Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Gwynne, Sarah, Sebag-Montefiore, David, Radhakrishna, Ganesh, Gollins, Simon, Hawkins, Maria, Grabsch, Heike I., Jones, Gareth, Falk, Stephen, Sharma, Ricky, Bateman, Andrew, Roy, Rajarshi, Ray, Ruby, Canham, Jo ORCID: https://orcid.org/0000-0003-3482-0990, Griffiths, Gareth, Maughan, Tim and Crosby, Tom 2017. NEOSCOPE: a randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma. European Journal of Cancer 74 , pp. 38-46. 10.1016/j.ejca.2016.11.031
file

Gwynne, Sarah, Jones, Gareth, Maggs, Rhydian, Eaton, David, Miles, Elizabeth, Staffurth, John ORCID: https://orcid.org/0000-0002-7834-3172, Nixon, Lisette ORCID: https://orcid.org/0000-0002-1270-6970, Ray, Ruby, Lewis, Geraint, Crosby, Tom and Spezi, Emiliano ORCID: https://orcid.org/0000-0002-1452-8813 2016. Prospective review of radiotherapy trials through implementation of standardised multi-centre workflow and IT infrastructure. British Journal of Radiology 89 , 20160020. 10.1259/bjr.20160020
file

Rees, J., Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Gollins, S., Mukherjee, S., Maughan, Timothy, Falk, S. J., Staffurth, John Nicholas ORCID: https://orcid.org/0000-0002-7834-3172, Ray, Ruby, Bashir Mohamad, Nurul, Geh, J. I., Cunningham, D., Roy, R., Bridgewater, J., Griffiths, G., Nixon, Lisette Sheena ORCID: https://orcid.org/0000-0002-1270-6970, Blazeby, J. M. and Crosby, T. 2015. Patient-reported outcomes during and after definitive chemoradiotherapy for oesophageal cancer. British Journal of Cancer 113 (4) , pp. 603-610. 10.1038/bjc.2015.258

Gollins, Simon, Sebag-Montefiore, David, Adams, Richard, Saunders, Mark P., Grieve, Robert, Scott, Nigel, Brown, Gina, Quirke, Philip, Butlin, Laura ORCID: https://orcid.org/0000-0003-2753-1883, Ray, Ruby, Griffiths, Gareth and Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355 2015. A phase II single arm feasibility trial of neoadjuvant chemotherapy (NAC) with oxaliplatin/fluorouracil (OxMdG) then short-course preoperative radiotherapy (SCPRT) then immediate surgery in operable rectal cancer (ORC): COPERNICUS (NCT01263171). Journal of Clinical Oncology 33 (15) , p. 3609.

Crosby, Thomas, Mukherjee, Somnath, Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Gwynne, Sarah, Gollins, Simon, Batrman, Andrew Rea, Lewis, Wyn Griffith, Radhakrishna, Ganesh, Hawkins, Maria, Grabsch, Heike I., Ray, Ruby, Sharma, Ricky A., Wade, Wendy, Maggs, Rhydian, Tranter, Bethan, Roberts, Ashley, Hadlow, Sue, Sebag-Montefiore, David, Maughan, Tim and Griffiths, Gareth 2014. NeoSCOPE: A phase II randomized comparison of neoadjuvant oxaliplatin/capecitabine versus carboplatin/paclitaxel-based chemoradiation in operable esophageal cancer [Abstract]. Journal of Clinical Oncology 32 (15_sup) , TPS4144. 10.1200/jco.2014.32.15_suppl.tps4144

Crosby, Thomas David Lewis, Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Falk, Stephen, Gollins, Simon, Mukherjee, Somnath, Staffurth, John Nicholas ORCID: https://orcid.org/0000-0002-7834-3172, Ray, Ruby, Bashir, Nadim, Bridgewater, John A., Geh, J. Ian, Cunningham, David, Blazeby, Jane, Roy, Rajarshi, Maughan, Timothy Stanley and Griffiths, Gareth O. 2013. Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial. The Lancet Oncology 14 (7) , pp. 627-637. 10.1016/S1470-2045(13)70136-0
file

Mukherjee, Somnath, Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Bridgewater, John, Falk, Stephen, Cummins, Sebastian, Wasan, Harpreet, Crosby, Thomas David Lewis, Jephcott, Catherine, Roy, Rajarshi, Radhakrishna, Ganesh, McDonald, Alec, Ray, Ruby, Joseph, George, Staffurth, John Nicholas ORCID: https://orcid.org/0000-0002-7834-3172, Abrams, Ross A., Griffiths, Gareth O. and Maughan, Timothy Stanley 2013. Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial. The Lancet Oncology 14 (4) , pp. 317-326. 10.1016/S1470-2045(13)70021-4
file

Crosby, T., Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Falk, S., Gollins, S., Mukherjee, Saptarshi, Staffurth, John Nicholas ORCID: https://orcid.org/0000-0002-7834-3172, Ray, Ruby, Bashir, N., Bridgwater, J., Geh, J. I., Cunningham, D., Blazeby, J., Roy, R., Maughan, T and Griffiths, Gareth 2013. SCOPE 1: A phase II/III trial of chemoradiotherapy in esophageal cancer plus or minus cetuximab. American Journal of Clinical Oncology 31 (Supp 4) , LBA3. 10.1200/jco.2013.31.4_suppl.lba3

This list was generated on Fri Mar 3 04:42:08 2023 GMT.